A patient friendly corifollitropin alfa protocol without routine pituitary suppression in normal responders

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Wang, Huai Ling ^a   Lai, Hsing Hua ^a   Chuang, Tzu Hsuan ^a   Shih, Yu Wei ^a   Huang, Shih Chieh ^a   Lee, Meng Ju ^a   Chen, Shee Uan ^b  

^a Stork Fertility Center   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CORIFOLLITROPIN ALFA; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT FOLLITROPIN PLUS RECOMBINANT LUTEINIZING HORMONE; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN; FOLLICLE STIMULATING HORMONE, HUMAN, WITH HCG C-TERMINAL PEPTIDE; FOLLITROPIN; GONADORELIN; HORMONE ANTAGONIST;

ADULT; ARTICLE; BIRTH RATE; BLASTOCYST; COHORT ANALYSIS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; LIVE BIRTH; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVULATION INDUCTION; PATIENT MONITORING; PERSONALIZED MEDICINE; RETROSPECTIVE STUDY; ANTAGONISTS AND INHIBITORS; BLOOD; CYTOLOGY; DRUG EFFECTS; IN VITRO FERTILIZATION; MALE; MIDDLE AGED; OVARY FOLLICLE; PREGNANCY; PREGNANCY RATE; PROCEDURES; YOUNG ADULT;

ADULT; BIRTH RATE; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; YOUNG ADULT;

EID: 84964598846     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154123     Document Type: Article

References (29)

1. Wildt L, Diedrich K, van der Ven H, al Hasani S, Hubner H, Hubner H, et al (1986) Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod 1:15-19. PMID: 2971082
2. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P, et al (2006) GnRH antagonists in ovarian stimulation for IVF. Hum Reprod 12:333-340.
3. Xiao JS, Su CM, Zeng XT (2014) Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis. PLoS One 9:e106854. doi: 10.1371/journal.pone.0106854 PMID: 25216031
4. Del Gadillo JC, Siebzehnrubl E, Dittrich R, Wildt L, Lang N (2002) Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol 102:179-183. PMID: 11950487
5. Frydman R, Cornel C, de Ziegler D, Taieb J, Spitz IM, Bouchard P (1992) Spontaneous luteinizing timely administration of a gonadotropin releasing hormone antagonist (Nal-Glu) during te late follicular phase. Hum Reprod 7: 930-933. PMID: 1430131
6. Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM (2010) Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF. Reprod Biomed Online 21:593-601. doi: 10.1016/j.rbmo.2010.06.032 PMID: 20843746
7. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM (2004) Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSHCTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 89:2062-2070. PMID: 15126522
8. Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC, ENGAGE Investigators (2009) A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 24:3063-3072. doi: 10.1093/humrep/dep291 PMID: 19684043
9. Pouwer AW, Farquhar C, Kremer JA (2012) Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database Syst Rev (online).
10. Lainas T, Zorzovilis J, Petsas G, Stavropoulou G, Cazlaris H, Daskalaki V, et al (2005) In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Hum Reprod 20:2426-2433. PMID: 15946995
11. Borm G, Mannaerts E (2000) Treatment with the gonadotrophin- releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 15:1490-1498. PMID: 10875855
12. Messinis IE, Loutradis D, Domali E, Kotsovassilis CP, Papastergiopoulou L, Kallitsaris A, et al (2005) Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment. Hum Reprod 20:3192-3197. PMID: 16037104
13. Wilcox J, Potter D, Moore M, Ferrande L, Kelly E (2005) Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril 84:108-117. PMID: 16009165
14. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S (2011) Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril 6:344-348.
15. Ferraretti AP, La Marco A, Fauser BC, Tarlazis B, Nargund G, Gianaroli L (2011) ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization the Bolonga criteria. Hum Reprod 7:1616-1624.
16. de Greef R, Zandvliet As, de Haan AF, Ijzerman-Boon PC, Marintcheva-Petrova M, Mannaerts BM (2010) Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. Clin Pharmacol Ther 88:79-87. doi: 10.1038/clpt.2010.54 PMID: 20520605
17. Griesinger G, Verweij PJ, Gates D, Devroey P, Gordon K, Stegmann BJ, et al (2016) Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS One 11:e0149615. doi: 10.1371/journal.pone.0149615 PMID: 26950065
18. Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Engel J, Diedrich K, et al (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15:526-531. PMID: 10686191
19. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, et al (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9:788-791. PMID: 7929723
20. Olivennes F, Cunha-Filho J S, Fanchin R, Bouchard P, Frydman R (2002) The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 8:279-290. PMID: 12078838
21. Seyhan A, Ata B (2011) The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist. Int J Women Health 3:243-255.
22. Messinis Ioannis E (2006) Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 12:557-571. PMID: 16672246
23. Fowler PA, Sorsa-Leslie T, Harris W, Mason HD (2003) Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research? Reproduction 126:689-699. PMID: 14748688
24. Messinis IE, Messini CI, Dafopoulos K (2014) Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online 28:714-722. doi: 10.1016/j.rbmo.2014.02.003 PMID: 24745832
25. Olivennes F, Diedrich K, Frydman R, Felberbaum RE, Howles CM (2003) Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences. Reprod Biomed Online 6:432-438. PMID: 12831588
26. Griesinger G, Dawson A, Schultze-Mosgau A, Finas D, Diedrich K, Felberbaum R (2006) Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol. Fertil Steril 85:791-793. PMID: 16500366
27. Messinis IE, Vanakara P, Zavos A, Verikouki C, Georgoulias P, Dafopoulos K (2010) Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women. Fertil Steril 94:1554-1556. doi: 10.1016/j.fertnstert.2009.12.055 PMID: 20149361
28. Reichman DE, Zakarin L, Chao K, Meyer L, Davis OK, Rosenwarks Z (2014) Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles. Fertil Steril 102:99-102. doi: 10.1016/j.fertnstert.2014.04.010 PMID: 24882557
29. Bhattacharya S, Maheshwari A, Mollison J (2013) Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles. PLoS One 8:e82249. doi: 10.1371/journal.pone. 0082249 PMID: 24349236